post-bg-601
calendary November 28, 2022

IVD regulatory approval process in European Union

Approaches to the regulation of in vitro diagnostic (IVD) medical devices vary by country. For example, in the United States, there is no separate classification for IVD devices, and a general regulatory system developed for medical devices is applied. If we talk about the European Union (EU), then the approach is different. For IVD products, a separate classification and a separate “main” legislative act have been developed - EU Regulation 2017/746.

It is important to note that a new version of this regulation has recently been released. The content of this document is the same as before, but some key dates (for example, the effective date of certain requirements for HIV and hepatitis tests) have been changed.

As in Russia and the USA, the registration of a medical device in the EU is largely determined by belonging to a certain class. In the EU, IVD products are divided into 4 classes: A, B, C, D. The classification is based on the intended use and risk class of the device (Article 47).

For devices of all classes, it is necessary to implement a quality management system that complies with Annex IX IVDR. Most companies use the ISO 13485 standard for this.

Further, for devices of all classes, a technical document is developed that reflects the compliance of the IVD with the requirements of Annexes II and III of the IVDR. In addition, registration in the EU requires an authorized representative (EU REP) with the appropriate qualification to carry out regulatory activities located in Europe. The data about EU REP (name and address) must be indicated on the instructions for medical use and packaging when selling products in the EU countries.

Also, for devices of all classes, it is necessary to register the manufacturer and IVD product in the EUDAMED database. The result is a unique product identification number (UDI).

Then for devices of classes B, C, D, an audit is carried out by a notified body in Europe. Based on the results of the audit, in case of a positive result, a CE marking is issued. Class A products do not pass this stage.

The manufacturer then prepares a Declaration of Conformity stating that the IVD product complies with the requirements of the IVDR (applicable to all product classes). The device can then be CE marked.

After that, class A devices can be sold, while the CE certificate is issued indefinitely. For other product classes, the notified body will have to carry out audits every 6-12 months to ensure compliance with the requirements of Annex 98/79/EC.

For class D devices, it is also necessary to analyze the batch and send the results to the notified body.

References:
  1. https://ec.europa.eu/commission/presscorner/detail/en/IP_21_5209
  2. https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32017R0746
  3. https://health.ec.europa.eu/system/files/2022-01/md_mdcg_2020_guidance_classification_ivd-md_en.pdf

More related posts

new-img-1

Control

Fine for spa resort in Yessentuki

Roszdravnadzor has imposed a fine of 130 thousand rubles on a spa resort in Yessentuki for improper storage of medical products…

03.03.2016
READ ARTICLE
new-img-2

Roszdravnadzor

Roszdravnadzor – patients’ rights

In 2015, Roszdravnadzor restored the rights of more than 460 thousand citizens to effective, accessible, and safe medical…

03.03.2016
READ ARTICLE
new-img-3

Regulation

The certification scheme for medical products hasn’t changed recently

Roszdravnadzor informs that the certification scheme for products in the Russian Federation is determined by Decree of the…

03.04.2016
READ ARTICLE
new-img-4

Control

Fines – Rostov region

In one and a half months of 2016, the Local Agency of Roszdravnadzor in Rostov Region imposed fines of the total amount of…

03.10.2016
READ ARTICLE
new-img-5

Control

Unregistered medical products

Two citizens were fined for selling unregistered medicinal products on the Internet in the Republic of Bashkortostan.

03.10.2016
READ ARTICLE
new-img-6

Control

Unscheduled inspection by roszdravnadzor

Roszdravnadzor started an unscheduled inspection of the Federal State-Funded Institution of Sverdlovsk Region Kirovgrad Central…

03.14.2016
READ ARTICLE
new-img-7

Medical Devices

International medical device regulators forum (IMDRF)

The delegation of the Federal Service for Surveillance in Healthcare headed by Mikhail Murashko, Head of Roszdravnadzor,…

03.17.2016
READ ARTICLE
new-img-8

Pharmaceuticals

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF”

Roszdravnadzor has suspended a series of the preparation “Paratsetomol-UBF” in which pills the metal wire was found.

05.18.2016
READ ARTICLE
new-img-9

Roszdravnadzor

Medical equipment stands idle in the Pskov region

Roszdravnadzor (RZN) statement: the expensive medical equipment for the total amount of 342 million rubles stands idle in…

05.19.2016
READ ARTICLE
new-img-10

Control

Hospital control Jewish autonomous region

Roszdravnadzor has audited the activity of the Regional Budgetary Public Health Facility “Central district hospital of Lenin”…

05.20.2016
READ ARTICLE